|
|
Volumn 33, Issue 5, 2009, Pages 283-286
|
|
The proceedings of the 17th international conference on chelation: Application of effective chelation therapies in iron loading and non iron loading conditions, and the gap in the prevention and treatment policies on thalassemia between developed and developing countries
a
|
|
Author keywords
Deferiprone (L1); Epidemiological data; Ethical issues; Non iron loading conditions; Optimal therapies; Thalassemia
|
|
Indexed keywords
DEFERASIROX;
DEFERIPRONE;
DEFEROXAMINE;
IRON;
IRON CHELATING AGENT;
ANTIOXIDANT ACTIVITY;
BLOOD TRANSFUSION;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DEVELOPED COUNTRY;
DEVELOPING COUNTRY;
DRUG EFFICACY;
FANCONI ANEMIA;
FRIEDREICH ATAXIA;
HEALTH CARE COST;
HEALTH CARE POLICY;
HETEROZYGOTE;
HOMOZYGOTE;
HUMAN;
IRON CHELATION;
IRON OVERLOAD;
KIDNEY DISEASE;
MULTICENTER STUDY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRENATAL DIAGNOSIS;
THALASSEMIA;
CHELATION THERAPY;
ECONOMICS;
EDITORIAL;
METABOLISM;
CHELATION THERAPY;
CLINICAL TRIALS AS TOPIC;
DEVELOPING COUNTRIES;
HUMANS;
IRON;
IRON CHELATING AGENTS;
IRON OVERLOAD;
THALASSEMIA;
|
|
EID: 70350672581
PISSN: 03630269
EISSN: 1532432X
Source Type: Journal
DOI: 10.3109/03630260903217257 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
